IC50 | 19000 nM | Bcl2-antagonist of cell death (BAD) | Q92934 | |
Potency | 398.1 nM | Prelamin-A/C | P02545 | |
Potency | 10000 nM | Nuclear factor NF-kappa-B p105 subunit | P19838 | |
Potency | 25118.9 nM | Regulator of G-protein signaling 12 | O14924 | |
Potency | 25118.9 nM | Lysine-specific demethylase 4D-like | B2RXH2 | |
Potency | 3981.1 nM | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | |
Potency | 12589.3 nM | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | |
Potency | 7079.5 nM | Lysine-specific demethylase 4D-like | B2RXH2 | |
Potency | 6309.6 nM | Huntingtin | P42858 | |
Potency | 10000 nM | Signal transducer and activator of transcription 6 | P42226 | |
Potency | 46109.1 nM | Ras-related protein Rab-9A | P51151 | |
Potency | 22387.2 nM | Survival motor neuron protein | Q16637 | |
Potency | 11220.2 nM | Survival motor neuron protein | Q16637 | |
Potency | 25118.9 nM | Thyroid stimulating hormone receptor | P16473 | |
Potency | 12589.3 nM | Thyroid stimulating hormone receptor | P16473 | |
Potency | 3162.3 nM | Cytochrome P450 2C19 | P33261 | |
Potency | 6309.6 nM | Cytochrome P450 2C19 | P33261 | |
Potency | 28183.8 nM | Microtubule-associated protein tau | P10636 | |
Potency | 7943.3 nM | Hypoxia-inducible factor 1 alpha | Q16665 | |
Potency | 10000 nM | Hypoxia-inducible factor 1 alpha | Q16665 | |
Potency | 22387.2 nM | Aldehyde dehydrogenase 1A1 | P00352 | |
Potency | 10000 nM | Pyruvate kinase isozymes M1/M2 | P14618 | |
Potency | 3162.3 nM | Arachidonate 15-lipoxygenase | P16050 | |
Potency | 7943.3 nM | Arachidonate 15-lipoxygenase | P16050 | |
Potency | 7943.3 nM | Hypoxia-inducible factor 1 alpha | Q16665 | |
Potency | 10000 nM | Hypoxia-inducible factor 1 alpha | Q16665 | |
Potency | 12589.3 nM | Arachidonate 12-lipoxygenase | P18054 | |
Potency | 10000 nM | Arachidonate 12-lipoxygenase | P18054 | |
Potency | 15848.9 nM | MAP kinase ERK2 | P28482 | |
Potency | 25118.9 nM | MAP kinase ERK2 | P28482 | |
Potency | 10000 nM | Pyruvate kinase isozymes M1/M2 | P14618 | |
Potency | 10000 nM | Nuclear factor NF-kappa-B p105 subunit | P19838 | |
Potency | 25118.9 nM | Thyroid stimulating hormone receptor | P16473 | |
Potency | 12589.3 nM | Thyroid stimulating hormone receptor | P16473 | |
Potency | 7943.3 nM | Signal transducer and activator of transcription 6 | P42226 | |
Potency | 25118.9 nM | MAP kinase ERK2 | P28482 | |
Potency | 25118.9 nM | Ubiquitin carboxyl-terminal hydrolase 2 | O75604 | |
Potency | 145809.7 nM | Niemann-Pick C1 protein | O15118 | |
Potency | 3288.5 nM | Serine/threonine-protein kinase mTOR | P42345 | |
Potency | 14125.4 nM | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | |
Potency | 1000 nM | Thrombopoietin | P40225 | |
Potency | 28183.8 nM | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | |
Potency | 12589.3 nM | Cellular tumor antigen p53 | P04637 | |
Potency | 3162.3 nM | Cellular tumor antigen p53 | P04637 | |
Potency | 31622.8 nM | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | |
Potency | 6309.6 nM | Cellular tumor antigen p53 | P04637 | |
Potency | 2511.9 nM | Cellular tumor antigen p53 | P04637 | |
Potency | 7943.3 nM | Signal transducer and activator of transcription 6 | P42226 | |
Potency | 3162.3 nM | Cytochrome P450 3A4 | P08684 | |
Potency | 31622.8 nM | Cytochrome P450 2D6 | P10635 | |
Potency | 12589.3 nM | Cytochrome P450 3A4 | P08684 | |
Potency | 7943.3 nM | Cytochrome P450 2D6 | P10635 | |
Potency | 15848.9 nM | Cytochrome P450 2C9 | P11712 | |
Potency | 3162.3 nM | Cytochrome P450 3A4 | P08684 | |
Potency | 1000 nM | Thrombopoietin | P40225 | |
Potency | 12589.3 nM | Cytochrome P450 3A4 | P08684 | |
Potency | 2908.1 nM | ATPase family AAA domain-containing protein 5 | Q96QE3 | |
Potency | 18356.4 nM | Nuclear factor erythroid 2-related factor 2 | Q16236 | |
Potency | 15848.9 nM | Histone acetyltransferase GCN5 | Q92830 | |
Potency | 56234.1 nM | Tumor susceptibility gene 101 protein | Q99816 | |
Potency | 12589.3 nM | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Q96KQ7 | |
Potency | 1888.8 nM | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Q96KQ7 | |
Potency | 9466.2 nM | Chromobox protein homolog 1 | P83916 | |
Potency | 3981.1 nM | Arachidonate 15-lipoxygenase, type II | O15296 | |
Potency | 3981.1 nM | Arachidonate 15-lipoxygenase, type II | O15296 | |
Potency | 580.2 nM | ATPase family AAA domain-containing protein 5 | Q96QE3 | |
Potency | 3162.3 nM | Glutaminase kidney isoform, mitochondrial | O94925 | |
Potency | 4610.9 nM | Dopamine D1 receptor | P21728 | |
Potency | 5623.4 nM | Ataxin-2 | Q99700 | |
Potency | 1995.3 nM | Ataxin-2 | Q99700 | |
Others | 15 % | Solute carrier organic anion transporter family member 2B1 | O94956 | |
Others | 2.9 % | Solute carrier organic anion transporter family member 1B3 | Q9NPD5 | |
Others | -0.2 % | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | |